Pharming Group N.V.
PHAR
$8.51
-$0.07-0.82%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | 2.86M | -1.22M | -3.12M | 3.46M | |
| Total Depreciation and Amortization | 1.82M | -293.00K | 1.76M | 2.90M | |
| Total Amortization of Deferred Charges | 852.00K | -- | 884.00K | -- | |
| Total Other Non-Cash Items | 10.89M | -2.43M | 13.45M | 1.73M | |
| Change in Net Operating Assets | -7.09M | -9.29M | -1.38M | -4.56M | |
| Cash from Operations | 9.33M | -13.22M | 11.58M | 3.53M | |
| Capital Expenditure | -130.00K | -214.00K | -304.00K | -147.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -9.66M | 36.61M | -3.60M | -58.08M | |
| Cash from Investing | -9.79M | 36.39M | -3.91M | -58.23M | |
| Total Debt Issued | 0.00 | 104.80M | -- | -- | |
| Total Debt Repaid | -1.52M | -135.69M | -191.00K | -1.01M | |
| Issuance of Common Stock | 2.09M | 2.58M | 253.00K | 8.55M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -2.78M | 7.00K | -1.08M | -2.30M | |
| Cash from Financing | -2.20M | -28.30M | -1.02M | 5.24M | |
| Foreign Exchange rate Adjustments | -3.06M | 381.00K | 439.00K | -913.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -5.72M | -4.75M | 7.09M | -50.37M | |